Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05089864 · ClinicalTrials.gov registry record · NA
STAR and Deferred Stenting Study
A NA study, sponsored by Saint Luke's Health System.
- Completed
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT05089864 is a NA study that has completed, run by Saint Luke's Health System. The registered enrollment target is 150 participants.
The verdict
NCT05089864, a NA study, has completed, sponsored by Saint Luke's Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timing of staged PCI. Five sites will be selected to participate in STAR from a national network of highly experienced CTO-PCI centers across the United States.
Interventions
- OTHER Stent Placement Timing - Early
- OTHER Stent Placement Timing - Late
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-11-23 |
| Est. Completion | 2025-08-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05089864
The ClinicalTrials.gov registry entry for NCT05089864 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stent Placement Timing - Early is the first listed.
NCT05089864 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05089864 about?
NCT05089864 is a clinical study titled "STAR and Deferred Stenting Study". STAR is a minimal-risk pragmatic clinical trial of patients admitted for a CTO-PCI procedure. The overall objective of the STAR Study is to address the current gaps in knowledge regarding use of STAR during CTO-PCI, as a prospective, multi-center study of 150 participants with randomization of timin...
What is the current status of trial NCT05089864?
This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2021-11-23. Estimated completion is 2025-08-07.
What interventions are being tested in trial NCT05089864?
The interventions under investigation include: Stent Placement Timing - Early (OTHER), Stent Placement Timing - Late (OTHER).
Who is sponsoring clinical trial NCT05089864?
This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.